HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Shinzaburo Noguchi Selected Research

Breast Neoplasms (Breast Cancer)

1/2016	Multi-gene classifiers for prediction of recurrence in breast cancer patients.
1/2016	One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
7/2015	C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis.
4/2015	Prediction of pathological complete response to neoadjuvant chemotherapy by magnetic resonance imaging in breast cancer patients.
4/2015	PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients.
1/2015	[Everolimus plus exemestane in postmenopausal patients with estrogen-receptor-positive advanced breast cancer - Japanese subgroup analysis of BOLERO -2].
1/2015	Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients.
1/2015	Personalization of loco-regional care for primary breast cancer patients (part 2).
12/2014	The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy.
11/2014	Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research network!

Shinzaburo Noguchi Research Topics

Disease

141	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2002
97	Neoplasms (Cancer) 09/2015 - 01/2002
22	Neoplasm Metastasis (Metastasis) 01/2016 - 01/2002
4	Disease Progression 05/2013 - 01/2010
3	Stomatitis 01/2015 - 02/2012
3	Wilms Tumor (Wilm's Tumor) 09/2004 - 05/2002
2	Hyperglycemia 11/2014 - 02/2012
2	Dyspnea (Shortness of Breath) 11/2014 - 02/2012
2	Anemia 11/2014 - 02/2012
2	Ductal Carcinoma 01/2013 - 01/2005
2	Obesity 03/2006 - 11/2003
2	Stomach Neoplasms (Stomach Cancer) 02/2006 - 01/2003
2	Lung Neoplasms (Lung Cancer) 09/2004 - 09/2002
2	Carcinoma (Carcinomatosis) 06/2004 - 01/2003
2	Adenoma (Adenomas) 07/2003 - 01/2002
1	Exanthema (Rash) 01/2015
1	Lung Diseases (Lung Disease) 01/2015

Drug/Important Bio-Agent (IBA)

42	Estrogens (Estrogen)FDA Link 09/2015 - 01/2002
28	Messenger RNA (mRNA)IBA 01/2016 - 01/2002
24	HormonesIBA 12/2014 - 05/2003
17	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015 - 01/2003
17	Paclitaxel (Taxol)FDA LinkGeneric 04/2015 - 11/2004
17	Epirubicin (Ellence)FDA LinkGeneric 04/2015 - 03/2003
17	Aromatase (CYP19)IBA 01/2015 - 01/2003
16	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 01/2003
16	Progesterone Receptors (Progesterone Receptor)IBA 07/2015 - 01/2002
16	Tamoxifen FDA LinkGeneric 05/2014 - 01/2002
16	docetaxel (Taxotere)FDA Link 01/2010 - 01/2002
12	anastrozole (Arimidex)FDA LinkGeneric 11/2014 - 01/2003
11	exemestane (Aromasin)FDA Link 01/2015 - 04/2003
10	Fluorouracil (Carac)FDA LinkGeneric 04/2015 - 04/2005
9	everolimus FDA Link 01/2015 - 02/2012
8	Aromatase InhibitorsIBA 11/2014 - 04/2003
7	capecitabine (Xeloda)FDA Link 03/2013 - 08/2006
6	Epidermal Growth Factor Receptor (EGF Receptor)IBA 07/2015 - 01/2009
6	TubulinIBA 03/2009 - 09/2002
5	CosmeticsIBA 03/2008 - 01/2002
5	Codon (Codons)IBA 07/2004 - 07/2002
4	ParaffinIBA 10/2014 - 02/2006
4	Goserelin (Zoladex)FDA Link 02/2013 - 01/2003
4	taxaneIBA 01/2013 - 03/2006
4	TaxoidsIBA 01/2013 - 09/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2011 - 01/2003
4	TegafurIBA 01/2010 - 01/2004
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007 - 12/2004
3	Phenobarbital (Luminal)FDA Link 01/2015 - 05/2012
3	letrozole (Femara)FDA LinkGeneric 11/2014 - 04/2003
3	EnzymesIBA 11/2014 - 05/2003
3	Glutathione Transferase (Glutathione S-Transferase)IBA 10/2014 - 05/2012
3	aldehyde dehydrogenase 1IBA 01/2013 - 06/2009
3	trastuzumab (Herceptin)FDA Link 09/2011 - 07/2009
3	UracilIBA 01/2010 - 04/2005
3	AdiponectinIBA 12/2008 - 11/2003
3	Interleukin-6 (Interleukin 6)IBA 11/2006 - 12/2004
3	Estradiol (Estrace)FDA LinkGeneric 12/2004 - 05/2003
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2016 - 06/2004
2	Hematoxylin (Haematoxylon)IBA 01/2016 - 06/2004
2	A-Form DNA (A-DNA)IBA 10/2014 - 01/2014
2	Formaldehyde (Formol)FDA Link 10/2014 - 06/2014
2	RNA (Ribonucleic Acid)IBA 06/2014 - 06/2007
2	Toremifene (Fareston)FDA Link 05/2014 - 07/2010
2	Epidermal Growth Factor (EGF)IBA 08/2013 - 12/2012
2	Sirolimus (Rapamycin)FDA Link 08/2013 - 02/2012
2	CyclinsIBA 01/2013 - 01/2009
2	Phosphotransferases (Kinase)IBA 01/2013 - 01/2009
2	Estrogen Receptor Modulators (Antiestrogen)IBA 09/2012 - 01/2003
2	Biological Tumor Markers (Tumor Markers)IBA 02/2012 - 09/2004
2	AnthracyclinesIBA 04/2010 - 07/2009
2	Estrogen Receptor betaIBA 01/2010 - 03/2003
2	Oxonic AcidIBA 01/2010 - 01/2004
2	doxifluridineIBA 01/2010 - 03/2003
2	Estrogen Receptor alphaIBA 01/2010 - 04/2006
2	gimeracilIBA 01/2010 - 01/2004
2	Adiponectin ReceptorsIBA 12/2008 - 06/2007
2	Glucose (Dextrose)FDA LinkGeneric 12/2008 - 05/2004
2	Factor IX (PTC)FDA LinkGeneric 04/2008 - 01/2002
2	ThioredoxinsIBA 02/2008 - 12/2005
2	InterleukinsIBA 11/2006 - 04/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2006 - 04/2006
2	Steryl-Sulfatase (Steroid Sulfatase)IBA 11/2006 - 06/2003
2	3 (or 17)-beta-hydroxysteroid dehydrogenaseIBA 11/2006 - 06/2003
2	AntigensIBA 09/2004 - 03/2004
2	WT1 ProteinsIBA 09/2004 - 07/2003
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 12/2003 - 07/2002
2	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 12/2003 - 05/2003
1	Estrogen ReceptorsIBA 07/2015
1	benthiocarb (Bolero)IBA 01/2015
1	hydrogen sulfite (bisulfite)IBA 01/2015

Therapy/Procedure

43	Drug Therapy (Chemotherapy) 01/2016 - 01/2002
9	Mastectomy (Mammectomy) 07/2015 - 04/2002
7	Segmental Mastectomy (Lumpectomy) 07/2015 - 11/2002
6	Adjuvant Chemotherapy 01/2016 - 03/2003
3	Aftercare (After-Treatment) 12/2013 - 07/2011
3	Neoadjuvant Therapy 04/2012 - 05/2008
3	Chemoprevention 10/2005 - 01/2003
2	Lymph Node Excision (Lymph Node Dissection) 10/2014 - 01/2002
2	Heterologous Transplantation (Xenotransplantation) 07/2011 - 01/2009
2	Combination Drug Therapy (Combination Chemotherapy) 07/2009 - 05/2008
2	Mammaplasty (Breast Reconstruction) 01/2007 - 11/2002
2	Immunotherapy 09/2004 - 03/2004